Nevertheless, our demonstration of increased PD-1+ T cells in the aging mouse prostate may still be useful information given the recent interest in developing immunotherapies targeting the PD-1/PD-L1 axis in prostate cancer [55–57]. The gene discussed is PDCD1; the disease is prostate carcinoma.